183 related articles for article (PubMed ID: 32930566)
1. Synthetic Fluorinated l-Fucose Analogs Inhibit Proliferation of Cancer Cells and Primary Endothelial Cells.
Dai Y; Hartke R; Li C; Yang Q; Liu JO; Wang LX
ACS Chem Biol; 2020 Oct; 15(10):2662-2672. PubMed ID: 32930566
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and analysis of potential α1,3-fucosyltransferase inhibitors.
Seelhorst K; Piernitzki T; Lunau N; Meier C; Hahn U
Bioorg Med Chem; 2014 Nov; 22(22):6430-7. PubMed ID: 25438767
[TBL] [Abstract][Full Text] [Related]
3. Development of α1,6-fucosyltransferase inhibitors through the diversity-oriented syntheses of GDP-fucose mimics using the coupling between alkyne and sulfonyl azide.
Manabe Y; Kasahara S; Takakura Y; Yang X; Takamatsu S; Kamada Y; Miyoshi E; Yoshidome D; Fukase K
Bioorg Med Chem; 2017 Jun; 25(11):2844-2850. PubMed ID: 28284868
[TBL] [Abstract][Full Text] [Related]
4. Fluorinated rhamnosides inhibit cellular fucosylation.
Pijnenborg JFA; Rossing E; Merx J; Noga MJ; Titulaer WHC; Eerden N; Veizaj R; White PB; Lefeber DJ; Boltje TJ
Nat Commun; 2021 Dec; 12(1):7024. PubMed ID: 34857733
[TBL] [Abstract][Full Text] [Related]
5. 2-Fluoro-L-Fucose Is a Metabolically Incorporated Inhibitor of Plant Cell Wall Polysaccharide Fucosylation.
Villalobos JA; Yi BR; Wallace IS
PLoS One; 2015; 10(9):e0139091. PubMed ID: 26414071
[TBL] [Abstract][Full Text] [Related]
6. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
[TBL] [Abstract][Full Text] [Related]
7. An Alkynyl-Fucose Halts Hepatoma Cell Migration and Invasion by Inhibiting GDP-Fucose-Synthesizing Enzyme FX, TSTA3.
Kizuka Y; Nakano M; Yamaguchi Y; Nakajima K; Oka R; Sato K; Ren CT; Hsu TL; Wong CH; Taniguchi N
Cell Chem Biol; 2017 Dec; 24(12):1467-1478.e5. PubMed ID: 29033318
[TBL] [Abstract][Full Text] [Related]
8. Differential gene expression of GDP-L-fucose-synthesizing enzymes, GDP-fucose transporter and fucosyltransferase VII.
Niittymäki J; Mattila P; Renkonen R
APMIS; 2006; 114(7-8):539-48. PubMed ID: 16907860
[TBL] [Abstract][Full Text] [Related]
9. Differential Labeling of Glycoproteins with Alkynyl Fucose Analogs.
Ma C; Takeuchi H; Hao H; Yonekawa C; Nakajima K; Nagae M; Okajima T; Haltiwanger RS; Kizuka Y
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825463
[TBL] [Abstract][Full Text] [Related]
10. Development of orally active inhibitors of protein and cellular fucosylation.
Okeley NM; Alley SC; Anderson ME; Boursalian TE; Burke PJ; Emmerton KM; Jeffrey SC; Klussman K; Law CL; Sussman D; Toki BE; Westendorf L; Zeng W; Zhang X; Benjamin DR; Senter PD
Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5404-9. PubMed ID: 23493549
[TBL] [Abstract][Full Text] [Related]
11. Modulation of GDP-fucose level for generating proteins with reduced rate of fucosylation (WO2010141855).
Taupin P
Expert Opin Ther Pat; 2011 Sep; 21(9):1497-9. PubMed ID: 21548846
[TBL] [Abstract][Full Text] [Related]
12. Reaction mechanism and substrate specificity for nucleotide sugar of mammalian alpha1,6-fucosyltransferase--a large-scale preparation and characterization of recombinant human FUT8.
Ihara H; Ikeda Y; Taniguchi N
Glycobiology; 2006 Apr; 16(4):333-42. PubMed ID: 16344263
[TBL] [Abstract][Full Text] [Related]
13. Fucosyltransferase-specific inhibition via next generation of fucose mimetics.
Martin KC; Tricomi J; Corzana F; García-García A; Ceballos-Laita L; Hicks T; Monaco S; Angulo J; Hurtado-Guerrero R; Richichi B; Sackstein R
Chem Commun (Camb); 2021 Jan; 57(9):1145-1148. PubMed ID: 33411866
[TBL] [Abstract][Full Text] [Related]
14. Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells.
Okagawa Y; Takada K; Arihara Y; Kikuchi S; Osuga T; Nakamura H; Kamihara Y; Hayasaka N; Usami M; Murase K; Miyanishi K; Kobune M; Kato J
PLoS One; 2016; 11(12):e0168355. PubMed ID: 27977808
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel FUT8 inhibitors with promising affinity and in vivo efficacy for colorectal cancer therapy.
Lv Y; Zhang Z; Wang M; Wang Y; Chen M; Jia J; Guo Y; Wang K; Li Z; Wang W; Li H
Bioorg Chem; 2024 Aug; 149():107492. PubMed ID: 38820939
[TBL] [Abstract][Full Text] [Related]
16. Metabolic inhibition of sialyl-Lewis X biosynthesis by 5-thiofucose remodels the cell surface and impairs selectin-mediated cell adhesion.
Zandberg WF; Kumarasamy J; Pinto BM; Vocadlo DJ
J Biol Chem; 2012 Nov; 287(47):40021-30. PubMed ID: 23019334
[TBL] [Abstract][Full Text] [Related]
17. Exogenous l-fucose attenuates neuroinflammation induced by lipopolysaccharide.
Xu X; Fukuda T; Takai J; Morii S; Sun Y; Liu J; Ohno S; Isaji T; Yamaguchi Y; Nakano M; Moriguchi T; Gu J
J Biol Chem; 2024 Jan; 300(1):105513. PubMed ID: 38042483
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of transition-state analogue inhibitors of alpha-1,3-fucosyltransferase.
Mitchell ML; Tian F; Lee LV; Wong CH
Angew Chem Int Ed Engl; 2002 Aug; 41(16):3041-4. PubMed ID: 12203452
[No Abstract] [Full Text] [Related]
19. Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome.
Rillahan CD; Antonopoulos A; Lefort CT; Sonon R; Azadi P; Ley K; Dell A; Haslam SM; Paulson JC
Nat Chem Biol; 2012 Jul; 8(7):661-8. PubMed ID: 22683610
[TBL] [Abstract][Full Text] [Related]
20. Donor substrate binding and enzymatic mechanism of human core α1,6-fucosyltransferase (FUT8).
Kötzler MP; Blank S; Bantleon FI; Spillner E; Meyer B
Biochim Biophys Acta; 2012 Dec; 1820(12):1915-25. PubMed ID: 22982178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
